Patent Assignment
Reel/Frame 052373/0131
Merger
Recorded: 2020-04-10
Pages: 3
Assignor
NEUROVANCE, INC.
Executed: 2017-11-30
Assignee
OTSUKA AMERICA PHARMACEUTICAL, INC.
2440 RESEARCH BLVD., ROCKVILLE, MARYLAND, 20850
Covered Property
(1)
Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
Application:
16/805,334 →
Publication:
US 2021/0023049
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 10, 2020
From: SKOLNICK, PHIL; BASILE, ANTHONY; CHEN, ZHENGMING; EPSTEIN, JOSEPH W.
To: DOV PHARMACEUTICAL, INC.
Reel/Frame 052366/0773 →
Merger and Change of Name
Apr 10, 2020
From: DOV PHARMACEUTICAL, INC.; DOV PHARMACEUTICAL, INC.
To: EUTHYMICS BIOSCIENCE, INC.
Reel/Frame 052371/0687 →
Assignment of Assignor's Interest
Apr 10, 2020
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 052373/0104 →
Assignment of Assignor's Interest
Apr 10, 2020
From: EUTHYMICS BIOSCIENCE, INC.
To: NEUROVANCE, INC.
Reel/Frame 052373/0116 →